Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial Evaluating Activity and Tolerability of Fixed Dose of Oxycodone and Increasing Dose of Pregabalin Versus Increasing Dose of Oxycodone and Fixed Dose of Pregabalin for the Treatment of Oncological Neuropathic Pain

NCT00637975 is registered in ClinicalTrials.gov with Associazione Progetto Oncologia UMAN.A as lead sponsor.

NCT NCT00637975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00637975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial Evaluating Activity and Tolerability of Fixed Dose of Oxycodone and Increasing Dose of Pregabalin Versus Increasing Dose of Oxycodone and Fixed Dose of Pregabalin for the Treatment of Oncological Neuropathic Pain
Lead sponsor
Associazione Progetto Oncologia UMAN.A
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
December 31, 2010
Enrollment
80 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pain